Expression of the genes of methyl-binding domain proteins in human gliomas
- PMID: 11836615
Expression of the genes of methyl-binding domain proteins in human gliomas
Abstract
DNA methylation is the most common epigenetic alteration in tumor genomes and might result in transcriptional repression of tumor suppressor genes. Moreover, recent results have demonstrated that both specific methylation patterns and functional components of the mismatch repair system are involved in the development of therapy resistance of tumor cells. Here we investigated the expression of the genes of methyl binding domain containing proteins (MBD) in human gliomas both in vivo and in vitro. We found expression of MBDs including MBD1, MBD2, MBD3 and MBD4/MED1 in all glioma cell lines and glioma biopsies. No differences existed in vitro with regard to individual MBDs and individual cell lines. In vivo, MBD1 and MBD2 were also expressed in all biopsies with only minor differences between individual tumors. MBD3 and MBD4/MED1, however, showed a correlation of expression with the grade of malignancy. Astrocytomas and anaplastic astrocytomas showed a weak expression compared with a high expression in glioblastoma multiforme.
Similar articles
-
The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.Oncogene. 2002 Jul 18;21(31):4822-9. doi: 10.1038/sj.onc.1205581. Oncogene. 2002. PMID: 12101420
-
Dynamic changes in the localization of five members of the methyl binding domain (MBD) gene family during murine and bovine preimplantation embryo development.Mol Reprod Dev. 2008 Jan;75(1):48-59. doi: 10.1002/mrd.20712. Mol Reprod Dev. 2008. PMID: 17546630
-
RET finger protein enhances MBD2- and MBD4-dependent transcriptional repression.Biochem Biophys Res Commun. 2006 Dec 8;351(1):85-92. doi: 10.1016/j.bbrc.2006.10.005. Epub 2006 Oct 10. Biochem Biophys Res Commun. 2006. PMID: 17049487
-
Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?Oncogene. 2002 Aug 12;21(35):5394-9. doi: 10.1038/sj.onc.1205631. Oncogene. 2002. PMID: 12154402 Review. No abstract available.
-
Role of MED1 (MBD4) Gene in DNA repair and human cancer.J Cell Physiol. 2001 May;187(2):137-44. doi: 10.1002/jcp.1064. J Cell Physiol. 2001. PMID: 11267993 Review.
Cited by
-
Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients.J Cancer. 2012;3:19-31. doi: 10.7150/jca.3.19. Epub 2011 Dec 9. J Cancer. 2012. PMID: 22211142 Free PMC article.
-
Beyond the marks: reader-effectors as drivers of epigenetics and chromatin engineering.Trends Biochem Sci. 2022 May;47(5):417-432. doi: 10.1016/j.tibs.2022.03.002. Trends Biochem Sci. 2022. PMID: 35427480 Free PMC article. Review.
-
Genotypes and haplotypes of the methyl-CpG-binding domain 2 modify breast cancer risk dependent upon menopausal status.Breast Cancer Res. 2005;7(5):R745-52. doi: 10.1186/bcr1283. Epub 2005 Jul 19. Breast Cancer Res. 2005. PMID: 16168120 Free PMC article.
-
Modifiers and Readers of DNA Modifications and Their Impact on Genome Structure, Expression, and Stability in Disease.Front Genet. 2016 Jun 21;7:115. doi: 10.3389/fgene.2016.00115. eCollection 2016. Front Genet. 2016. PMID: 27446199 Free PMC article. Review.
-
Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.Cancer Res. 2014 Mar 15;74(6):1752-65. doi: 10.1158/0008-5472.CAN-13-0884. Epub 2014 Jan 22. Cancer Res. 2014. PMID: 24453002 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous